Search results
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 9 hours agoModerna Stock: Technical...The RS Rating is a 1-99 measure of a stock's 12-month performance. This...
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 7 days agoThe biotech company aims to bring as many as 15 new products to market over the next five years and has the late-stage pipeline to support...is set to...
Who will RFK Jr. hurt more in 2024: Trump or Biden?
Yahoo News 360· 9 hours ago12%); that vaccines cause autism (25% vs. 5%); and that chemicals in the water supply could turn children transgender (8% vs. 4%). For now, the Yahoo...
Zoetis Inc. (ZTS) Q1 2024 Earnings: Strong Growth in Revenue and Net Income
GuruFocus.com via Yahoo Finance· 13 hours agoThis growth was driven by a 12% operational increase in revenue. Net income also saw a rise,...
On doorstep of approval, Merck compares V116 pneumococcal vaccine to 1983 warhorse Pneumovax 23
FierceBiotech· 4 days agoFive months ago, Merck revealed data that indicate its next-generation pneumococcal vaccine offers more protection for older adults than Pfizer’s market dominator Prevnar ...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 1 day agoSI&A spending is expected in the range of $13...billion to $14.8 billion. The adjusted tax rate is...
FDA Says Vaccination Is the Best Protection Against Measles
Sierra Sun Times· 4 days agoMeasles is one of the most contagious respiratory diseases in the world that has the potential to be life-threatening. Vaccines approved by the U.S. Food and Drug Administration ...
Realising the potential of correlates of protection for vaccine development, licensure and use:...
Nature· 4 days agoVaccines have had a significant impact on global morbidity and mortality over the last century, with estimates indicating that millions of lives are saved each year as a result ...
FDA finalizes lab test regulations with more flexibility
Politico· 2 days agoNordic has started submitting data to the FDA for approval of its chikungunya vaccine, aiming to complete the submission by the end of June, the company ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 1 day agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...